Inovio Pharmaceuticals, Inc. · NASDAQ:INO
Vanguard Capital Management LLC reported a 5.05% stake in Inovio Pharmaceuticals, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 31, 2026
Vanguard Capital Management LLC reported a 5.05% stake in Inovio Pharmaceuticals, Inc., 4,161,566 shares, as a passive investor on Jun 30, 2026. Filed Jul 31, 2026 (Schedule 13G).
- Stake
- 5.05%
- Shares
- 4,161,566
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.05% | 4,161,566 |
Source
Related
- Inovio Pharmaceuticals, Inc.
- Vanguard Capital Management LLC
- Inovio Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G · Ra Capital Management, L.P. · Aug 7, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Form 4 · Humeau Laurent · May 21, 2026
- Form 4 · Sumner Michael John · May 21, 2026